{"id":44236,"date":"2022-05-23T22:01:01","date_gmt":"2022-05-23T20:01:01","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/"},"modified":"2022-05-23T22:01:01","modified_gmt":"2022-05-23T20:01:01","slug":"ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/","title":{"rendered":"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services"},"content":{"rendered":"
\n

\nSonarMD\u2019s platform pinpoints patients in need of mental health support better than claims data alone<\/i>\n<\/p>\n

CHICAGO–(BUSINESS WIRE)–#IBD<\/a>—SonarMD<\/a>, the leading care coordination company for gut health, will present an abstract at Digestive Disease Week (DDW) 2022 demonstrating the importance of proactive screening for mental health conditions in patients with inflammatory bowel diseases (IBD). SonarMD is using this data to identify and connect IBD patients to services that promote emotional well-being and healthy sleep, via new partnerships with Happy<\/a> and Rise Science<\/a>.\n<\/p>\n

<\/a><\/p>\n

\nSonarMD will present abstract at DDW<\/i><\/b>\n<\/p>\n

\nMental health issues like emotional distress and poor sleep can worsen IBD outcomes and increase the risk of hospitalization and surgery, driving up the cost of care. But patients with these co-morbidities cannot be fully identified by retrospective claims data alone, according to new data being presented at DDW.\n<\/p>\n

\nSonarMD data reveals a nearly 40% increase in cost of care for IBD patients who have a positive depression screening score but no mental health claim in their history, compared to the general IBD population. That\u2019s nearly twice the cost increase than when analyzing retrospective claims data alone.\n<\/p>\n

\n\u201cMental health can have a major impact on the course of disease for patients with chronic digestive illness, but challenges often go undetected,\u201d said Lawrence Kosinski, MD, MBA, lead abstract author and SonarMD\u2019s founder and chief medical officer. \u201cWe have to be proactive in screening patients and connecting them to clinically relevant services that meet their individual needs \u2014 before those needs become health emergencies.\u201d\n<\/p>\n

\nIn addition to the data being presented at DDW, SonarMD has previously shown care costs are 26% higher for IBD patients with claims related to sleep disorders.\n<\/p>\n

\nThe SonarMD platform uniquely combines multi-payer claims data, clinical information and patient-reported outcome measures, including Patient Health Questionnaire 2 (PHQ-2) depression screening scores, to better identify patients who would benefit from additional support services.\n<\/p>\n

\nSonarMD expands to support whole person care<\/i><\/b>\n<\/p>\n

\nTo help patients better manage their health, SonarMD is piloting partnerships with Happy and Rise Science to deliver emotional health and sleep management support at no cost to patients or practices. RISE is an app that uses sleep and circadian science and phone data to help patients improve their sleep and manage their energy, and Happy is a peer-based service pioneering \u201cfrictionless mental health\u201d that uses a proactive engagement model to improve patients\u2019 emotional wellbeing and reduce barriers to care. SonarMD is introducing these holistic services with the first patient cohorts this spring. This launch will also establish wearable device integrations for seamless remote monitoring, supporting future incremental expansions in diet and nutrition and beyond.\n<\/p>\n

\n\u201cI\u2019m excited to see SonarMD offer more holistic tools and services in the care management of our patients with inflammatory bowel disease,\u201d said Nadeem Baig, MD, vice president of Allied Digestive Health and chief medical officer of the Allied Health Management Services Organization. \u201cSonarMD is an extension of our practice, so these new services further augment our ability to manage the health and well-being of our patients with chronic disease.\u201d\n<\/p>\n

\nDDW poster details<\/i><\/b>\n<\/p>\n

\nSession Title<\/b>: Health Economics (Cost of Illness, Cost-Effectiveness, and Health Economic Models)
\n
Session Sponsor<\/b>: AGA
\n
Session Date and Time<\/b>: May 23, 2022 from 12:30 PM to 1:30 PM
\n
Poster Presentation Title<\/b>: MENTAL HEALTH DISORDERS ARE ASSOCIATED WITH INCREASED COST IN IBD PATIENTS \u2013 USE OF RETROSPECTIVE CLAIMS DATA AND PHQ-2 CAN IDENTIFY HIGH-RISK HIGH-COST POPULATIONS OF IBD
\n
Poster Number<\/b>: Mo1057\n<\/p>\n

\nAbout Digestive Disease Week\u00ae (DDW)<\/span><\/b>\n<\/p>\n

\nDigestive Disease Week\u00ae (DDW) is the largest international gathering of physicians, researchers and academics in the fields of gastroenterology, hepatology, endoscopy and gastrointestinal surgery. Jointly sponsored by the American Association for the Study of Liver Diseases (AASLD), the American Gastroenterological Association (AGA) Institute, the American Society for Gastrointestinal Endoscopy (ASGE) and the Society for Surgery of the Alimentary Tract (SSAT), DDW takes place May 21 \u2013 24 in San Diego, California and virtually. The meeting showcases more than 3,100 abstracts and hundreds of lectures on the latest advances in GI research, medicine and technology. More information can be found at www.ddw.org<\/a>.\n<\/p>\n

\nAbout SonarMD<\/b>\n<\/p>\n

\nSonarMD aligns incentives around the doctor-patient relationship to reimagine care for complex chronic diseases, starting in gastroenterology. Using AI technology and human support, we predict clinical deterioration in patients and make it easier for patients and specialists to work together to proactively address problems before they become health emergencies. Our approach is proven to keep people healthier and help health plans reduce costs by 15% per member per year. For more information, visit SonarMD.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nPatty Keiler, patty@collaborate.health<\/a>, 312-550-5394\n<\/p>\n

\n\u00a0\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

SonarMD\u2019s platform pinpoints patients in need of mental health support better than claims data alone CHICAGO–(BUSINESS WIRE)–#IBD—SonarMD, the leading care coordination company for gut health, will present an abstract at Digestive Disease Week (DDW) 2022 demonstrating the importance of proactive screening for mental health conditions in patients with inflammatory bowel diseases (IBD). SonarMD is using … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44236","6":"format-standard","7":"category-industry"},"yoast_head":"\nDDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"SonarMD\u2019s platform pinpoints patients in need of mental health support better than claims data alone CHICAGO–(BUSINESS WIRE)–#IBD—SonarMD, the leading care coordination company for gut health, will present an abstract at Digestive Disease Week (DDW) 2022 demonstrating the importance of proactive screening for mental health conditions in patients with inflammatory bowel diseases (IBD). SonarMD is using ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-23T20:01:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220523005133\/en\/1462918\/21\/Full_Color_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services\",\"datePublished\":\"2022-05-23T20:01:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/\"},\"wordCount\":767,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005133\\\/en\\\/1462918\\\/21\\\/Full_Color_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/\",\"name\":\"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005133\\\/en\\\/1462918\\\/21\\\/Full_Color_Logo.jpg\",\"datePublished\":\"2022-05-23T20:01:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005133\\\/en\\\/1462918\\\/21\\\/Full_Color_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220523005133\\\/en\\\/1462918\\\/21\\\/Full_Color_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/","og_locale":"en_US","og_type":"article","og_title":"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services - Pharma Trend","og_description":"SonarMD\u2019s platform pinpoints patients in need of mental health support better than claims data alone CHICAGO–(BUSINESS WIRE)–#IBD—SonarMD, the leading care coordination company for gut health, will present an abstract at Digestive Disease Week (DDW) 2022 demonstrating the importance of proactive screening for mental health conditions in patients with inflammatory bowel diseases (IBD). SonarMD is using ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-23T20:01:01+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220523005133\/en\/1462918\/21\/Full_Color_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services","datePublished":"2022-05-23T20:01:01+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/"},"wordCount":767,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005133\/en\/1462918\/21\/Full_Color_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/","url":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/","name":"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220523005133\/en\/1462918\/21\/Full_Color_Logo.jpg","datePublished":"2022-05-23T20:01:01+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220523005133\/en\/1462918\/21\/Full_Color_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220523005133\/en\/1462918\/21\/Full_Color_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/ddw22-sonarmd-data-shows-hidden-impact-of-mental-health-on-ibd-costs-company-expands-access-to-support-services\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"DDW22: SonarMD Data Shows Hidden Impact of Mental Health on IBD Costs, Company Expands Access to Support Services"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44236"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44236\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}